Genotype frequencies of the insulin gene polymorphisms in the sample groups
| Marker . | Genotype . | UKPDS LADA (n = 232)* . | W2 Repository LADA (n = 131)* . | Exeter YT2D LADA (n = 37)* . | All cases (n = 400)* . | Control subjects (n = 332)* . |
|---|---|---|---|---|---|---|
| −23HphI | ||||||
| AA | 165 (0.71) | 81 (0.62) | 30 (0.81) | 276 (0.69) | 159 (0.49) | |
| AT | 58 (0.25) | 40 (0.31) | 4 (0.11) | 102 (0.26) | 141 (0.43) | |
| TT | 8 (0.04) | 10 (0.08) | 3 (0.08) | 21 (0.05) | 27 (0.08) | |
| +1404Fnu4HI | ||||||
| CC | 182 (0.80) | 89 (0.69) | 30 (0.81) | 301 (0.76) | 199 (0.61) | |
| CA | 42 (0.18) | 31 (0.24) | 5 (0.14) | 78 (0.20) | 105 (0.32) | |
| AA | 5 (0.02) | 10 (0.08) | 2 (0.05) | 17 (0.04) | 20 (0.06) | |
| +3580MspI | ||||||
| CC | 81 (0.35) | 50 (0.39) | 20 (0.54) | 151 (0.38) | 147 (0.45) | |
| CT | 97 (0.42) | 60 (0.46) | 12 (0.32) | 169 (0.42) | 143 (0.43) | |
| TT | 53 (0.23) | 20 (0.15) | 5 (0.14) | 78 (0.20) | 39 (0.12) |
| Marker . | Genotype . | UKPDS LADA (n = 232)* . | W2 Repository LADA (n = 131)* . | Exeter YT2D LADA (n = 37)* . | All cases (n = 400)* . | Control subjects (n = 332)* . |
|---|---|---|---|---|---|---|
| −23HphI | ||||||
| AA | 165 (0.71) | 81 (0.62) | 30 (0.81) | 276 (0.69) | 159 (0.49) | |
| AT | 58 (0.25) | 40 (0.31) | 4 (0.11) | 102 (0.26) | 141 (0.43) | |
| TT | 8 (0.04) | 10 (0.08) | 3 (0.08) | 21 (0.05) | 27 (0.08) | |
| +1404Fnu4HI | ||||||
| CC | 182 (0.80) | 89 (0.69) | 30 (0.81) | 301 (0.76) | 199 (0.61) | |
| CA | 42 (0.18) | 31 (0.24) | 5 (0.14) | 78 (0.20) | 105 (0.32) | |
| AA | 5 (0.02) | 10 (0.08) | 2 (0.05) | 17 (0.04) | 20 (0.06) | |
| +3580MspI | ||||||
| CC | 81 (0.35) | 50 (0.39) | 20 (0.54) | 151 (0.38) | 147 (0.45) | |
| CT | 97 (0.42) | 60 (0.46) | 12 (0.32) | 169 (0.42) | 143 (0.43) | |
| TT | 53 (0.23) | 20 (0.15) | 5 (0.14) | 78 (0.20) | 39 (0.12) |
Data are n (frequency).
Individuals in whom genotyping was attempted.